Biomanufacturing Symposium at BIOTECHNICA 2009

Collaboration of drug developers and manufacturers

22-Sep-2009 - The second edition of this year’s Biomanufacturing Symposium on 7th October 2009 at BIOTECHNICA in Hannover (Germany), offers an ideal exchange platform for biopharma drug developers and manufacturers. This one-day event jointly organised by Capgemini Consulting and Deutsche Messe will address ...

NNE Pharmaplan launched as a joint company

20-Apr-2007 - NNE Pharmaplan has been officially launched as a joint company following NNE's acquisition of the German engineering company Pharmaplan GmbH which was completed on 31 March 2007. According to the company, Pharmaplan supplements NNE with know-how in delivery of turnkey facilities, validation and ...

Vetter Pharma-Fertigung Wins International Innovation Award

05-Apr-2007 - Vetter Pharma-Fertigung GmbH & Co. KG was announced as the winner in the Process Innovation category of the third annual Facility of the Year Awards (FOYA). The contract manufacturer from Ravensburg, Germany was the only European company selected by the judging panel, recognising state-of-the-art ...

Alkermes and Lilly Expand AIR Inhaled Insulin Collaboration

10-Jan-2007 - Alkermes, Inc. and Eli Lilly and Company announced that they have signed a commercial manufacturing agreement for AIR® Inhaled Insulin (AIR® Insulin). As a result of the agreement, Alkermes will be the exclusive commercial manufacturer of AIR Insulin powder for the AIR® Inhaled Insulin System ...

Aureus Pharma extends collaboration with Sanofi-Aventis

13-Jun-2005 - Aureus Pharma, a provider of knowledge management solutions to aid discovery in the life sciences industry, announced that sanofi-aventis has become its first customer for the company's recently released AurSCOPE® Ion Channel database. This agreement extends the collaboration between Aureus ...

Poll Reveals Data Management Inefficiencies Lengthen Drug Discovery Process

05-Jun-2002 - WESTBOROUGH, MA (June 3, 2002) - Inefficiencies in data management and a significant increase in the amount of data generated in today's modern laboratories are contributing to a slower drug discovery process, suggests a recent poll conducted by NuGenesis Technologies Corporation. The poll was ...

Exelixis and Merck Establish Chemistry Collaboration

Companies Combine Chemistry Expertise to Create Novel Libraries

02-May-2002 - SOUTH SAN FRANCISCO, Calif. May 1, 2002 Exelixis, Inc. has established a collaboration with Merck & Co., Inc. for the joint design and generation of small molecule compound libraries for high throughput drug screening. These custom libraries will be owned by both companies and will be designed ...

Nastech and Pharmacia in Worldwide Agreement

06-Feb-2002 - Nastech Pharmaceutical Company and Pharmacia Corporation have announced an agreement for the development and marketing of Nastech's proprietary nasally administered apomorphine product for the treatment of erectile dysfunction (ED) and female sexual dysfunction (FSD). Nastech's proprietary nasal ...

Galapagos Genomics and Procter & Gamble Pharmaceuticals Announce Functional Genomics Collaboration

23-Oct-2001 - Galapagos Genomics NV, the Belgian functional genomics company, and Procter & Gamble Pharmaceuticals (P&GP), a division of The Procter & Gamble Company (NYSE: PG – news) today announced a collaboration in which P&GP will use Galapagos’ adenovirus technology as a tool to validate the utility of ...

PPD Discovery Signs Technology Agreement With InforMax

Gains Access to GenoMax Enterprise Bioinformatics System

01-Mar-2001 - PPD Discovery, a wholly owned drug discovery subsidiary of PPD, Inc. (Nasdaq: PPDI), announced today a technology access agreement with InforMax, Inc. (Nasdaq: INMX) to use the GenoMax(TM) enterprise bioinformatics system. Under the terms of the agreement, PPD Discovery will gain broad access ...